Search by Drug Name or NDC

    NDC 70518-1274-00 Abacavir 300 mg/1 Details

    Abacavir 300 mg/1

    Abacavir is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by REMEDYREPACK INC.. The primary component is ABACAVIR SULFATE.

    Product Information

    NDC 70518-1274
    Product ID 70518-1274_02a9e373-9b68-e981-e063-6394a90a5e7d
    Associated GPIs 12105005100320
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Abacavir
    Proprietary Name Suffix n/a
    Non-Proprietary Name Abacavir
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name ABACAVIR SULFATE
    Labeler Name REMEDYREPACK INC.
    Pharmaceutical Class Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078119
    Listing Certified Through 2024-12-31

    Package

    NDC 70518-1274-00 (70518127400)

    NDC Package Code 70518-1274-0
    Billing NDC 70518127400
    Package 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-1274-0)
    Marketing Start Date 2018-06-21
    NDC Exclude Flag N
    Pricing Information N/A